GSK3B and familial dilated cardiomyopathy: To the best of our knowledge, this study is the inaugural identification of the beneficial impact of RVS or PTS in milieu DCM via curbing the ROS/TLR/NF-κB as well as regulating AKT/GSK3β signaling cascades.